MedicarePartD.guide

A non-government resource built from CMS public data

HIV treatment and prevention on every 2026 South Carolina Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 11 stand-alone Part D plans in South Carolina cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days

11 plans, cheapest premium first. Scroll sideways for all of them →

HIV treatment and prevention by 2026 South Carolina Part D plan
DrugWellcare Value Script$4.80/moS4802-144Wellcare Classic$9.70/moS4802-070Humana Basic Rx Plan$10.10/moS5884-134Humana Value Rx Plan$65.60/moS5884-188HealthSpring Extra Rx$71.20/moS5617-359SilverScript Choice$98.40/moS5601-018AARP Medicare Rx Saver from UHC$122.10/moS5921-354AARP Medicare Rx Preferred from UHC$139.20/moS5921-391BlueCross Rx Value$139.70/moS5953-001Humana Premier Rx Plan$145.60/moS5884-155HealthSpring Assurance Rx$152.50/moS5617-218
Biktarvybictegravir/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%Tier 525%Tier 525%QL 30/30dTier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%
Dovatodolutegravir and lamivudineTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%Tier 525%Tier 525%QL 30/30dTier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%
Triumeqabacavir/dolutegravir/lamivudineTier 440%Tier 427%Tier 430%QL 180/30dTier 434%QL 180/30dTier 430%QL 300/30dTier 433%Tier 436%QL 180/30dTier 435%QL 180/30dTier 450%QL 180/30dTier 450%QL 180/30dTier 431%QL 300/30d
Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%QL 30/30d
Odefseyemtricitabine/rilpivirine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%QL 30/30d
Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamideTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%Tier 525%Tier 525%QL 30/30dTier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%
Julucadolutegravir and rilpivirineTier 525%Tier 525%Tier 525%QL 30/30dTier 526%QL 30/30dTier 525%Tier 525%Tier 525%QL 30/30dTier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%
Descovyemtricitabine and tenofovir alafenamideTier 525%QL 30/30dTier 525%QL 30/30dTier 525%QL 30/30dTier 526%QL 30/30dTier 525%QL 30/30dTier 525%Tier 525%QL 30/30dTier 531%QL 30/30dTier 525%QL 30/30dTier 533%QL 30/30dTier 525%QL 30/30d
Truvadaemtricitabine and tenofovir disoproxilNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
emtricitabine-tenofovirgeneric TruvadaTier 440%QL 30/30dTier 427%QL 30/30dTier 430%QL 30/30dTier 434%QL 30/30dTier 430%QL 30/30dTier 433%QL 30/30dTier 436%QL 30/30dTier 435%QL 30/30dTier 2$17.00QL 30/30dTier 450%QL 30/30dTier 431%QL 30/30d
TivicaydolutegravirTier 525%Tier 525%Tier 525%QL 60/30dTier 526%QL 60/30dTier 430%QL 180/30dTier 525%Tier 525%QL 60/30dTier 531%QL 60/30dTier 450%QL 180/30dTier 533%QL 60/30dTier 431%QL 180/30d

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.